There have been several new medications developed for Parkinson’s disease in recent years. Some of them include:
- Inbrija (levodopa inhalation powder): Inbrija is a new medication that delivers levodopa (the primary treatment for Parkinson’s disease) in the form of an inhalable powder. It is used as a rescue treatment for Parkinson’s patients experiencing “off” episodes.
- Ongentys (opicapone): Ongentys is a medication that prolongs the effect of levodopa by inhibiting the enzyme that breaks it down. It is used in combination with levodopa/carbidopa to treat Parkinson’s disease.
- Nourianz (istradefylline): Nourianz is a medication that works by blocking adenosine receptors in the brain, which can improve the motor symptoms of Parkinson’s disease. It is used as an adjunct to levodopa/carbidopa therapy.
- Xadago (safinamide): Xadago is a medication that inhibits the breakdown of dopamine in the brain, which can help alleviate motor symptoms of Parkinson’s disease. It can be used alone or in combination with levodopa/carbidopa.
It’s important to note that while these medications have shown promise in clinical trials, they may not be suitable or effective for everyone with Parkinson’s disease. Always consult with your doctor before starting or stopping any medication.